# TMC435-TiDP16-C112 - Interaction Trial With Antidepressants

> **NCT01090700** · PHASE1 · COMPLETED · sponsor: **Tibotec Pharmaceuticals, Ireland** · enrollment: 20 (actual)

## Conditions studied

- Hepatitis C Virus

## Interventions

- **DRUG:** TMC435
- **DRUG:** Escitalopram
- **DRUG:** TMC435 + Escitalopram

## Key facts

- **NCT ID:** NCT01090700
- **Lead sponsor:** Tibotec Pharmaceuticals, Ireland
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01090700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01090700, "TMC435-TiDP16-C112 - Interaction Trial With Antidepressants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01090700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*